Correspondence 0001193125-23-149408 from BIOLASE, INC (BIOL) (CIK 0000811240)
BIOLASE, INC (BIOL) (CIK 0000811240)
Date: May 19, 2023 · CIK: 0000811240 · Accession: 0001193125-23-149408
AI Filing Summary & Sentiment
File numbers found in text: 333-271660
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 19, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Biolase, Inc. Registration Statement on Form S-1, as amended File No. 333-271660 Request for Acceleration of Effective Date Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Securities Act”), Lake Street Capital Markets, LLC, as the representative of the several underwriters, hereby joins in the request of Biolase, Inc. for acceleration of the effective date of the above-referenced registration statement on Form S-1, as amended (the “Registration Statement”), so that it becomes effective as of 5:00 p.m. Eastern Time on Tuesday, May 23, 2023, or as soon thereafter as possible. Pursuant to Rule 460 of the General Rules and Regulations of the Securities Act, we wish to advise you that we have distributed approximately 400 copies of the preliminary prospectus to prospective underwriters, institutional investors, dealers and others. The undersigned has and will comply, and it has been informed or will be informed by any participating dealers that they have complied or will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, LAKE STREET CAPITAL MARKETS, LLC As Representative of the Several Underwriters Named in the Underwriting Agreement By: /s/ Michael Townley Name: Michael Townley Title: Head of Investment Banking